The role of urethral dilation in managing pediatric neurogenic bladder dysfunction

被引:0
|
作者
Wan J. [1 ]
机构
[1] Department of Urology, University of Michigan, Ann Arbor, MI, 48109, 3875 Taubman 0330
关键词
Lower Urinary Tract Symptom; Neurogenic Bladder; Anticholinergic Medication; Clean Intermittent Catheterization; Leak Point Pressure;
D O I
10.1007/s11884-008-0020-9
中图分类号
学科分类号
摘要
Urethral dilation is an effective method of treating children with neurogenic bladders who have poor bladder compliance, high leak point pressure, and are unresponsive to standard therapy with anticholinergic medications and clean intermittent catheterization. Urethral dilation can be successfully applied to boys and girls and has few side effects. There are no demonstrated long-term effects on continence. However, the use of urethral dilation has been limited by two factors: 1) general disregard given to urethral dilation when applied to children and adults with recurrent urinary tract infections and lower urinary tract symptoms, and 2) the general efficacy of conventional therapy that limits the number of children who may actually benefit from the procedure. © 2008 Springer Science+Business Media, LLC.
引用
收藏
页码:127 / 132
页数:5
相关论文
共 50 条
  • [31] BLADDER DEFORMITIES IN PATIENTS WITH NEUROGENIC BLADDER DYSFUNCTION
    OGAWA, T
    UROLOGIA INTERNATIONALIS, 1991, 47 : 59 - 62
  • [32] Anomalies of the external urethral meatus in girls with non-neurogenic bladder sphincter dysfunction - Reply
    Hoebeke, P
    BJU INTERNATIONAL, 2001, 87 (03) : 281 - 281
  • [33] Pharmacotherapy for Pediatric Neurogenic Bladder
    Kroll, Pawel
    PEDIATRIC DRUGS, 2017, 19 (05) : 463 - 478
  • [34] The Management of the Pediatric Neurogenic Bladder
    Sturm R.M.
    Cheng E.Y.
    Current Bladder Dysfunction Reports, 2016, 11 (3) : 225 - 233
  • [35] Pharmacotherapy for Pediatric Neurogenic Bladder
    Paweł Kroll
    Pediatric Drugs, 2017, 19 : 463 - 478
  • [36] Management of pediatric neurogenic bladder
    MacLellan, Dawn L.
    CURRENT OPINION IN UROLOGY, 2009, 19 (04) : 407 - 411
  • [37] Drug Development for Pediatric Neurogenic Bladder Dysfunction: Dosing, Endpoints, and Study Design
    Momper, Jeremiah D.
    Karesh, Alyson
    Green, Dionna J.
    Hirsch, Mark
    Khurana, Mona
    Lee, Jinoo
    Kim, Myong-Jin
    Mulugeta, Yeruk
    Sachs, Hari C.
    Yao, Lynne
    Burckart, Gilbert J.
    JOURNAL OF CLINICAL PHARMACOLOGY, 2014, 54 (11): : 1239 - 1246
  • [38] MULTICENTER URETHROPLASTY OUTCOMES FOR URETHRAL STRICTURE DISEASE FOR PATIENTS WITH NEUROGENIC BLADDER OR BLADDER DYSFUNCTION REQUIRING CLEAN INTERMITTENT CATHETERIZATION
    Cohen, Andrew
    Cheng, Philip
    Song, Sikai
    Patino, German
    Myers, Jeremy
    Roy, Samit
    Elliot, Sean
    Pariser, Joseph
    Drobish, Justin
    Erickson, Bradley
    Fuller, Thomas
    Buckley, Jill
    Vanni, Alex
    Baradaran, Nima
    Breyer, Benjamin
    JOURNAL OF UROLOGY, 2020, 203 : E516 - E516
  • [39] Pediatric Neurogenic Bladder and Bowel Dysfunction: Will My Child Ever Be out of Diapers?
    Johnston, Ashley W.
    Wiener, John S.
    Purves, J. Todd
    EUROPEAN UROLOGY FOCUS, 2020, 6 (05): : 838 - 867
  • [40] Multicenter urethroplasty outcomes for urethral stricture disease for patients with neurogenic bladder or bladder dysfunction requiring clean intermittent catheterization
    Cohen, Andrew J.
    Cheng, Philip J.
    Song, Sikai
    Patino, German
    Myers, Jeremy B.
    Roy, Samit S.
    Elliott, Sean P.
    Pariser, Joseph
    Drobish, Justin
    Erickson, Brad A.
    Fuller, Thomas W.
    Buckley, Jill C.
    Vanni, Alex J.
    Baradaran, Nima
    Breyer, Benjamin N.
    TRANSLATIONAL ANDROLOGY AND UROLOGY, 2021, 10 (05) : 2035 - 2042